Skip to content

Trial on Education And Clinical Outcomes for Home PD Patients (TEACH)

Trial on Education And Clinical Outcomes for Home PD Patients (TEACH)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01204619
Acronym
TEACH
Enrollment
104
Registered
2010-09-17
Start date
2010-12-31
Completion date
2016-03-31
Last updated
2016-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Risk Reduction

Keywords

peritoneal dialysis

Brief summary

Since the emergence of home peritoneal dialysis as an alternative to in-center hemodialysis for chronic renal replacement therapy in the late 1970s, the percentage of dialysis patients on PD has continued to decrease each year. There have been a growing concern and research on patient and technique survival of peritoneal dialysis versus hemodialysis to find influential factors for better clinical outcomes. Meanwhile, technique failure rates were significantly higher in small centers treating less than twenty five PD patients. And there was a result for better technique survival after the second year, among the patients trained at the BREC(Baxter Renal Education Center). Better technique survival in large centers can be assumed with not only their more experience with patient management but also their educational infrastructure compared to small-sized centers. Throughout our experiences in the last 30 years, we have recognized that a major element of PD program is patient training, however few data are available in terms of the relationship between PD training and treatment outcome and mostly are retrospective and non-randomized. Moreover, the technique survival and patient survival were analyzed with no significant difference. From the insight, we decided to study prospectively to evaluate the efficacy of well-structured education program in terms of various patient outcomes in incident patients on PD.

Detailed description

This study will be conducted as multi-center, open-label, randomized, controlled trial. One hundred four patient starting PD will be randomized into two training groups. Patients in the conventional training group (CG) will be given non-standardized in-center conventional training programs plus two sessions of training by home visit, while those in intensive training group (IG) given in-center conventional training programs plus repeated home visits regularly over 24-month period (total thirteen visits). The primary end point of the study is exit site infection (ESI). Secondary endpoints are peritonitis and all-cause infection. Generalized Estimating Equations will be used to assess the adjusted effect of training level on the ESI and Cox regression model employed to evaluate the effect on the peritonitis and other secondary outcomes.

Interventions

BEHAVIORALIntensive training group

an extra structured patient centric training program on PD technique and diet according to the developed training curriculum

Sponsors

Baxter Healthcare Corporation
CollaboratorINDUSTRY
Kook-Hwan Oh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Incident patients who have PD catheter insertion for starting PD with Baxter solutions * \> 20 yr of age

Exclusion criteria

* Patients who have undergone dialysis or received kidney transplant (note, however, that patients who are currently undergoing emergency hemodialysis temporarily right before the PD do not fall under the

Design outcomes

Primary

MeasureTime frame
Exit site infection24 months

Secondary

MeasureTime frame
Number of ESIs per patient-month24 months
Days of hospitalization per year24 months
Systolic pressure and diastolic pressure measured at every visit24 months
Average number of antihypertensive medications24 months
Kt/V24 months
Residual renal function24 months
Fluid balance score24 months
Patient survival rate24 months
Total medical cost24 months
Total hours of education and training24 months
Unplanned home visit and education by peritoneal dialysis nurse24 months
time to the first peritonitis24 months
HbA1c only for patients with diabetes24 months
Intact PTH level24 months
Hemoglobin level24 months
nPNA24 months
QOL24 months
SGA24 months
K level24 months
Total number of hospitalizations by cause over the last 1 and/or 2 years after the dialysis24 months
Technical survival rate24 months
peritonitis rate24 months
Compliance score of patients24 months

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026